Type of Program:
Genome Canada has launched a national initiative for the clinical implementation of precision health, focusing on a rare disease pilot program as a foundational step. This project aims to translate research into clinical implementation with the goal of having genome sequencing offered as a clinical genetic test within an established diagnostic and clinical care pathway for rare diseases.
Comments on Funding:
Funding is up to 1/3 of the project budget from Genome Canada, from a minimum contribution of $100,000 to a maximum of $2 million.
The remaining project funding must be secured from other eligible sources, with at least 1/3 provided by the Receptor(s).
When It Ends:
Eligible projects must:
The applicant is an academic researcher and he must be:
The Receptors must:
Applicants must submit their GAPP applications and the supporting documents via a regional Genome Centre.
They must contact their regional Genome Centre for more information.
Other Things to Note:
Genome Canada is again welcoming Expressions of Interest for the GAPP. Please contact your Regional Genome Centre for more information on the application process and timelines (June, 2021).